Allogene Therapeutics (ALLO) Insider Trading & Ownership $2.21 +0.10 (+4.74%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Allogene Therapeutics (NASDAQ:ALLO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.30%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$5.00 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$76,536.00 Get ALLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALLO Insider Buying and Selling by Quarter Ad Chaikin Analytics50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Allogene Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/30/2024Franz B HumerDirectorSell11,200$2.34$26,208.00 5/16/2024Arie BelldegrunDirectorBuy1,724,137$2.90$4,999,997.30 1/30/2024Geoffrey M ParkerCFOBuy190$3.60$684.00 12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.00 (Data available from 1/1/2013 forward) ALLO Insider Trading Activity - Frequently Asked Questions Who is on Allogene Therapeutics's Insider Roster? The list of insiders at Allogene Therapeutics includes Alison Moore, Arie Belldegrun, David D Chang, Deborah M Messemer, Eric Thomas Schmidt, Franz B Humer, Geoffrey M Parker, Owen N Witte, Rafael Amado, Stephen Mayo, and Veer Bhavnagri. Learn more on insiders at ALLO. What percentage of Allogene Therapeutics stock is owned by insiders? 24.30% of Allogene Therapeutics stock is owned by insiders. Learn more on ALLO's insider holdings. Which Allogene Therapeutics insiders have been buying company stock? The following insiders have purchased ALLO shares in the last 24 months: Arie Belldegrun ($4,999,997.30), and Geoffrey M Parker ($684.00). How much insider buying is happening at Allogene Therapeutics? Insiders have purchased a total of 1,724,327 ALLO shares in the last 24 months for a total of $5,000,681.30 bought. Which Allogene Therapeutics insiders have been selling company stock? The following insiders have sold ALLO shares in the last 24 months: Deborah M Messemer ($50,328.00), Franz B Humer ($26,208.00), Stephen Mayo ($42,900.00), and Veer Bhavnagri ($83,853.06). How much insider selling is happening at Allogene Therapeutics? Insiders have sold a total of 51,442 Allogene Therapeutics shares in the last 24 months for a total of $203,289.06 sold. Allogene Therapeutics Key ExecutivesDr. Arie S. Belldegrun F.A.C.S. (Age 75)M.D., Co-Founder & Executive Chairman Compensation: $649.1kDr. David D. Chang M.D. (Age 64)Ph.D., Co-Founder, President, CEO & Director Compensation: $994.6kMr. Joshua A. Kazam (Age 47)Co-Founder & Director Compensation: $260.5kMr. Timothy L. Moore Ph.D. (Age 63)Executive VP & Chief Technical Officer Compensation: $554.35kDr. Zachary J. Roberts M.D. (Age 46)Ph.D., Executive VP of Research & Development and Chief Medical Officer Compensation: $747.39kMr. Geoffrey M. Parker (Age 59)Executive VP & CFO Ms. Annie Yoshiyama (Age 40)Senior VP, Corporate Controller & Principal Accounting Officer Mr. Earl M. Douglas Esq. (Age 61)Senior VP, General Counsel, Compliance Officer & Corporate Secretary Ms. Susan R. Lundeen (Age 58)Chief People Officer Ms. Christine CassianoExecutive VP, Chief Corporate Affairs & Brand Strategy Officer More Insider Trading Tools from MarketBeat Related Companies Fate Therapeutics Insider Ownership bluebird bio Insider Ownership Recursion Pharmaceuticals Insider Ownership Immunocore Insider Ownership Neumora Therapeutics Insider Ownership BioCryst Pharmaceuticals Insider Ownership Novavax Insider Ownership Vir Biotechnology Insider Ownership LENZ Therapeutics Insider Ownership Relay Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ALLO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALLO Stock Alerts